Please assess the completion status of the following clinical trial:

Trial Title: Craniomaxillofacial Allotransplantation

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria:~* Signed and dated all required IRB approved consent forms~* Male or female recipient between the ages of 18-64 years. \* Recipients do not need to be same gender as donor\*~* Facial composite tissue defect requiring facial transplantation as determined by the treating Plastic and Reconstructive Surgeon. Inclusive facial functional subunit tissue loss. Including but not limited to irreparable peri-oral, peri-orbital, and peri-nasal damage.~* Patient has been encouraged to seek a second opinion from a Plastic Surgeon with specialized focus in facial reconstruction.~* Willingness to participate in ongoing psychiatric, psychological and social work evaluations prior to and post-transplant surgery~* The subject is able to complete pre-transplant examination and screening procedures.~* Patient has been approved by Patient Selection Committee for placement on the recipient waiting list~* The subject is willing to continue immunosuppression regimen as directed by treating physician.~* Subject is willing and able to return to follow-up visits as described in treatment plan.~* Subjects must have autogenous tissue options available for reconstruction in event of graft failure.~* Normal GFR (glomerular filtration rate) \>60~* Negative pregnancy test within 48hrs of transplant for women of childbearing age and who agree to use a reliable form of contraception for one year following transplant.~Exclusion criteria:~* Subject has an uncontrolled infection~* Serious co-morbidities~* Positive serology for HIV; Hepatitis B/C Antigen~* Active malignancy within 5 years with the exclusion of non-melanoma~* Subject has active substance abuse/ alcoholism~* Active Severe Psychiatric Illness~* Cognitive limitations affecting the patient's ability to provide informed consent~* Recent history of medical nonadherence~* Unstable social situation as evidence by lack of stable housing and/or lack of a supportive significant other.~* Recent history of medical non-adherence.~* Lack of stable housing and/or supportive significant other/caregiver throughout all phases of the study~* Currently active smoker within 1 year~* Subjects with any cognitive deficits related to a TBI (traumatic brain injury) and or any organic neurological disorders will not be considered for this protocol.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- Face Transplant recipient (Type: EXPERIMENTAL): Single Arm study, all participants will receive Craniomaxillofacial allotransplantation

Based on this trial design, predict the completion outcome and termination type (if applicable).